Alterations in insulin signaling in humans are associated with a vast number of risk factors or co-morbid conditions including obesity, cardiovascular disease, and intermittent hypoxia conditions, such as obstructive sleep apnea. This evidence concerns the gene INS and obstructive sleep apnea syndrome.